4//SEC Filing
HAUSMAN DIANA 4
Accession 0000899243-20-032791
CIK 0001403752other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 7:45 PM ET
Size
14.0 KB
Accession
0000899243-20-032791
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
HAUSMAN DIANA
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Shares
2020-12-04$9.82/sh+2,850$27,987→ 6,568 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-04−2,850→ 68,028 totalExercise: $9.82From: 2018-06-12Exp: 2027-06-12→ Common Shares (2,850 underlying) - Sale
Common Shares
2020-12-04$55.12/sh−6,032$332,476→ 3,718 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-04−3,182→ 47,673 totalExercise: $11.84From: 2019-03-19Exp: 2028-03-18→ Common Shares (3,182 underlying) - Exercise/Conversion
Common Shares
2020-12-04$11.84/sh+3,182$37,675→ 9,750 total
Holdings
- 2,000(indirect: By Spouse)
Common Shares
Footnotes (3)
- [F1]Pursuant to a 10b5-1 plan.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.00 to $55.38, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 4, 2020 at each separate price.
- [F3]Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following the first anniversary of grant date. The grant date was ten years before the listed expiration date.
Documents
Issuer
Zymeworks Inc.
CIK 0001403752
Entity typeother
Related Parties
1- filerCIK 0001563992
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 7:45 PM ET
- Size
- 14.0 KB